Bayer Australia is aware of media reports regarding a Statement of Claim about glyphosate
but has not received a writ at this time. We have great sympathy for any individual with cancer, but the extensive body of science on glyphosate-based herbicides over four decades supports the conclusion that Roundup does not cause Non-Hodgkin's Lymphoma (NHL).
Glyphosate has been extensively studied globally by scientists and regulators, and results from this research confirm it is not carcinogenic. We firmly stand behind the safety of glyphosate-based products, and as a company devoted to life sciences, assure Australians that their health and the environment are our top priority.
At the end of the day, whether you're in the court of law, regulatory agencies or court of public opinion, it's the science that should matter here. The extensive body of science over 40 years, including several recent human epidemiology studies, shows that glyphosate-based herbicides are not associated with NHL. Customers who know these products best continue to rely on them. Bayer stands behind these products and will vigorously defend them.
Bayer encourages constructive dialogue with our stakeholders to build a broader trust in science. We are dedicated to being open and transparent and have published extensive research, which supports our products’ safety. We are committed to ensuring our customers continue to have access to these critical products as part of their sustainable agricultural activities.
There is an extensive body of research on glyphosate and Bayer’s glyphosate-based herbicides, including more than 800 rigorous scientific studies. Scientific studies have been submitted to and reviewed by U.S., Canadian, European, Australian and other transparent and rigorous science based regulators in connection with the registration process for glyphosate-based products. Regulators globally continue to confirm that glyphosate-based products are safe when used as directed.
In 2016, the Australian Pesticides and Veterinary Medicines Authority (APVMA) conducted a weight-of-evidence evaluation that included a commissioned review of the IARC monograph by the Department of Health, risk assessments undertaken by expert international bodies and regulatory agencies and concluded that ‘glyphosate does not pose a carcinogenic risk to humans and that there are no grounds to place it under formal reconsideration’.
The independent 2018 National Cancer Institute supported Agricultural Health Study – the largest and most recent epidemiologic study conducted, which followed over 50,000 licensed pesticide applicators for more than 20 years – found no association between glyphosate-based herbicides and cancer.
In 2017, the U.S. EPA’s cancer risk assessment examined more than 100 studies the agency considered relevant and concluded that glyphosate is ‘not likely to be carcinogenic to humans,’ its most favourable rating.
Benefits of glyphosate:
Glyphosate-based herbicides have been used safely and successfully for over four decades worldwide and are a valuable tool to help Australian farmers deliver crops to markets and practice sustainable farming.
Glyphosate-based herbicides help farmers deliver crops to markets while promoting sustainable farming by reducing soil tillage, soil erosion, and carbon emissions.